Ming Lei, based in United States, is currently a CEO at Universal Sequencing Technology. Ming Lei brings experience from previous roles at Haemonetics, THE Blood Management Company, 454 Life Sciences/Roche Diagnostics, BioMicro Systems (acquired by Roche NimbleGen) and BioMicro Systems. Ming Lei holds a 1996 - 1997 The Johns Hopkins University School of Medicine. With a robust skill set that includes Biotechnology, Lifesciences, Microfluidics, DNA sequencing, Sequencing and more. Ming Lei has 2 emails and 2 mobile phone numbers on RocketReach.
Get contact details of over 700M profiles across 60M
companies – all with industry-leading accuracy. Sales and Recruiter users, try out our
Email Finder Extension.
Find business and personal emails and mobile phone numbers
with exclusive coverage across niche job titles, industries, and more
for unparalleled targeting. Also
available via our
Contact Data API.